Shanghai, China & Aachen, Germany — MicroPort Scientific Corporation (hereinafter referred to as “MicroPort®”) announced on October 4 th , 2021, through its critical care subsidiary, MicroPort Surgical B.V. (“MicroPort® Surgery”), has acquired 100% of the equity held by existing shareholders of Hemovent GmbH (hereinafter referred to as “Hemovent”) for a total cash consideration of up to €123 million. Upon completion of the acquisition, Hemovent will become a wholly-owned subsidiary of MicroPort®.
↧
MicroPort Acquires German ECLS Company Hemovent GmbH and Invests in Expansion of German Operations
↧